Skip to content
    NKTR stock page

    NEKTAR THERAPEUTICS

    NKTR · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 13, 2026

      Nektar Therapeutics Q2 FY26 — Phase III REZPEG Programs Advancing, Strong Cash Position

      Read the brief

    Browse all US companies on the earnings-call register.